PURA and PAOG Look To Tissue Culture Technology For Pharma Cannabis Cultivation

Dallas, TX --  Nov. 22, 2021 -- Puration, Inc. (OTC Pink: PURA) and PAO Group, Inc. (OTC Pink: PAOG) today announced plans to pursue tissue culture technology for their pharmaceutical-grade cannabis cultivation initiative. A recent announcement by Pharmagreen Biotech, Inc. (OTC Pink: PHBI) got the attention of the two companies.

“[PHBI] is in the business of providing the highest quality starter plantlets utilizing a proprietary tissue culture process, "Chibafreen", to licensed cannabis cultivators and to CBD / CBG hemp farmers.”

PURA has launched a cooperative hemp industry branding strategy under the name Farmersville Hemp. PAOG is a CBD pharmaceutical and nutraceutical technology company that is a partner in PURA’s Farmersville Hemp initiative.

PURA and PAOG are working together to build an extraction lab and pharmaceutical-grade cultivation facility as part of the Farmersville Hemp Brand facilities under construction in Farmersville, Texas.

PURA and PAOG management, upon initial research, are optimistic a tissue culture technology would add value to their overall extract and cultivation initiative.

For more information on Puration, visit http://www.purationinc.com

Learn more about PAOG at www.paogroupinc.com

Disclaimer:

This News Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause our actual results, performance or achievements, or industry results, to differ materially from any these statements. You are cautioned not to place undue reliance on any those forward-looking statements. Except as otherwise required by the federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements after the date of this news release. None of such forward-looking statements should be regarded as a representation by us or any other person that the objectives and plans set forth in this News Release will be achieved or be executed.

For More Information Contact:

Puration, Inc.
Brian Shibley,
[e-mail]
[phone]

Jim DiPrima
888-272-6472
[e-mail]